Silver Book Fact

Increased use of a blood-thinning drug prevents 40,000 strokes every year in the U.S.

Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1. AHRQ Web site. http://www.ahrq.gov/clinic/strokcln.htm. Published June 2000

Reference

Title
Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1
Publication
AHRQ
Publication Date
Published June 2000
Authors
Matchar D, Samsa G
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Data from clinical trials demostrate that ICDs reduce sudden cardiac death 5-10% per year for 2-3 years, compared to antiarrhythmic drugs.  
  • Heart Failure Disease Management (DM) Program Reduces Hospitalizations and Overall Costs  
  • About 70% of the survival improvement in heart attack mortality resulted from changes in technology.  
  • Effectiveness of an oral pharmacologic agent in preventing venous thrombosis
    An oral pharmacologic agent has been demonstrated to be at least as effective as an injectable anticoagulant in the prevention of venous thrombosis following hip replacement.  
  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.